MedPath

Addition of Silver Nanoparticles to a Orthodontic Primer in Preventing Enamel Demineralization Adjacent Brackets

Phase 3
Conditions
Tooth Demineralization
Interventions
Other: Silver nanoparticles
Other: Placebo
Registration Number
NCT02400957
Lead Sponsor
Universidad Autonoma de San Luis Potosí
Brief Summary

Evaluate the effectiveness of silver nanoparticles incorporated into the primer orthodontic Transbond XT in preventing enamel demineralization adjacent to brackets.

Detailed Description

Randomized, split mouth, double-blind, placebo controlled trial. Half of the mouth was applied silver nanoparticles incorporated into the primer orthodontic Transbond XT and the other half with primer-bond as placebo. Evaluate the effectiveness with Diagnodent - pen in preventing enamel demineralization adjacent to brackets.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients candidates for orthodontic treatment.
Read More
Exclusion Criteria
  • Patients with O.D 11 and / or 21 absent.

    • Patients who present dentures of any kind in OD 11 and 21.
    • Patients presenting endodontic OD 11 and 21.
    • Patients presenting data gingivitis day cementing brackets.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Silver nanoparticlesSilver nanoparticlesHalf of the mouth was applied silver nanoparticles. Allocation was randomized.
PlaceboPlaceboHalf of the mouth was applied placebo. Allocation was randomized.
Primary Outcome Measures
NameTimeMethod
enamel demineralization (Diagnodent - pen evaluation)8 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gabriela Moreno Meraz

🇲🇽

San Luis Potosi, Mexico

© Copyright 2025. All Rights Reserved by MedPath